(Note: Biotech Group Acquisition Corp. withdrew its plans for a $75.0 million SPAC IPO in a March 26, 2024, letter to the SEC. The Irvine, California-based SPAC had filed plans to go public on April 15, 2022.) We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of […]

We shall not undertake our initial business combination with any company being based in or having the majority of the company’s operations in China (including Hong Kong and Macau). Our Certificate of Incorporation to be adopted upon the effectiveness of this prospectus prohibit us from undertaking our initial business combination with any company being based […]

We intend to focus our search on companies within the consumer and retail industry. Our affiliation with EF Hutton will allow us to leverage the knowledge and expertise of not only Messrs. Piggott, Rallo and Boral but also of all 54 investment professionals currently employed at the organization. **(Note: EF Hutton is the sole book-running […]

(Note: Laris Media Acquisition Corp. withdrew its SPAC IPO in an SEC filing dated April 19, 2022; the S-1 filed on March 19, 2021.) We intend to focus our search for a target business operating in the audio industry in North America. (Incorporated in the Cayman Islands) We are focused on identifying a business combination target […]

We intend to focus on operating businesses in the biotechnology or telecommunications, media, and technology, or TMT, industries in Asia and North America, evaluated based on, among other things, sustainability and environmental, social, and corporate governance, or ESG, imperatives. (Incorporated in the Cayman Islands)

(Note: Reborn Coffee, Inc. upsized its IPO at pricing on Aug. 11, 2022, to 1.44 million shares, up from 1.2 million in the prospectus, and priced the IPO at $5.00, the assumed IPO price, to raise $7.2 million. The stock is expected to start trading Friday, Aug. 12, 2022, on the NASDAQ. The timing of […]

(Note: Foresite Life Sciences Corp., a SPAC or blank-check company, withdrew its stock-only SPAC IPO in an SEC filing dated April 15, 2022. The company filed its S-1 (prospectus) on Feb. 26, 2021; it filed its last S-1/A on May 6, 2021. Most SPAC IPOs are unit offerings of stock and warrants. Foresite Life Sciences […]

(Note: ForU Worldwide Inc. withdrew its IPO in an SEC filing dated April 19, 2022. This was an IPO of American Depositary Shares (ADS), with no pricing terms stated, according to an F-1/A filing dated June 2, 2021. The F-1 (prospectus) was filed May 13, 2021. ForU Worldwide filed confidentially for an IPO on March […]

  We are a clinical biopharmaceutical company focused on developing and commercializing novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. It is estimated that norovirus causes nearly 700 million cases of illness and more than 200,000 deaths worldwide per year, as well […]

We are a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Our Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated […]